A 24-week Clinical Trial to Study the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
Status:
Recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in
participants with inadequately controlled eosinophilic asthma to evaluate improvements in
lung function, asthma control, and quality of life. In addition, the study will further
evaluate the safety and tolerability of dexpramipexole in participants with eosinophilic
asthma.